Transcriptional Regulation in Prostate Cancer

Cold Spring Harb Perspect Med. 2018 Nov 1;8(11):a030437. doi: 10.1101/cshperspect.a030437.

Abstract

Prostate cancer development involves corruption of the normal prostate transcriptional network, following deregulated expression or mutation of key transcription factors. Here, we provide an overview of the transcription factors that are important in normal prostate homeostasis (NKX3-1, p63, androgen receptor [AR]), primary prostate cancer (ETS family members, c-MYC), castration-resistant prostate cancer (AR, FOXA1), and AR-independent castration-resistant neuroendocrine prostate cancer (RB1, p53, N-MYC). We use functional (in vitro and in vivo) as well as clinical data to discuss evidence that unveils their roles in the initiation and progression of prostate cancer, with an emphasis on results of chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq).

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Androgens / genetics
  • Genes, Neoplasm / genetics
  • Hepatocyte Nuclear Factor 3-alpha / genetics
  • Humans
  • Male
  • Prostatic Neoplasms / genetics*
  • Prostatic Neoplasms, Castration-Resistant / genetics
  • Proto-Oncogene Proteins c-myc / genetics
  • Receptors, Androgen / genetics
  • Signal Transduction / genetics
  • Transcription, Genetic / genetics*

Substances

  • AR protein, human
  • Androgens
  • FOXA1 protein, human
  • Hepatocyte Nuclear Factor 3-alpha
  • Proto-Oncogene Proteins c-myc
  • Receptors, Androgen

Grants and funding